miR-124 suppressed the migration and invasion of pituitary adenoma cells by targeting FSCN1, pituitary tumor-transforming gene 1 protein-interacting protein (PTTG1IP), and Ezrin (EZR) [37]. This evidence concerns the gene PTTG1IP and pituitary gland adenoma.